On February 28, 2025, Biosig Technologies, Inc. entered into an agreement allowing it to sell up to $5 million of its common stock to Lind Global Fund III, LP over 36 months, with certain conditions and limits on the number of shares. The company will issue 108,542 shares to the investor as part of this agreement.